BE896678A - Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments. Download PDF

Info

Publication number
BE896678A
BE896678A BE1/10783A BE1010783A BE896678A BE 896678 A BE896678 A BE 896678A BE 1/10783 A BE1/10783 A BE 1/10783A BE 1010783 A BE1010783 A BE 1010783A BE 896678 A BE896678 A BE 896678A
Authority
BE
Belgium
Prior art keywords
emi
formula
compounds
pyridinones
cyano
Prior art date
Application number
BE1/10783A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE896678A publication Critical patent/BE896678A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE1/10783A 1982-05-18 1983-05-06 Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments. BE896678A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH308782 1982-05-18

Publications (1)

Publication Number Publication Date
BE896678A true BE896678A (fr) 1983-11-07

Family

ID=4248332

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/10783A BE896678A (fr) 1982-05-18 1983-05-06 Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments.

Country Status (3)

Country Link
JP (1) JPS58213759A (hu)
BE (1) BE896678A (hu)
ZA (1) ZA833584B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024A2 (de) 1985-04-30 1986-11-05 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO760996L (hu) * 1975-03-25 1976-09-28 Byk Gulden Lomberg Chem Fab
ZA807267B (en) * 1979-11-26 1981-11-25 Sterling Drug Inc 5-(pyridinyl)-2(1h)-pyridinones,useful as cardiotonic agents and their preparation
US4271168A (en) * 1979-12-26 1981-06-02 Sterling Drug Inc. Selected 3-acylamino-5-[4(or 3)-pyridinyl]-2(1H)-pyridinones
ZA821818B (en) * 1981-03-30 1983-02-23 Sterling Drug Inc 3-amino-5-(substituted)-2 (1h)-pyridinones and 3-cyano compounds useful as cardiotonics and preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024A2 (de) 1985-04-30 1986-11-05 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Also Published As

Publication number Publication date
JPH0443065B2 (hu) 1992-07-15
ZA833584B (en) 1984-12-24
JPS58213759A (ja) 1983-12-12

Similar Documents

Publication Publication Date Title
BE1013212A6 (fr) Procede de preparation de citalopram pur.
FR2517303A1 (fr) Derives d'imidazole
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
FR2658511A1 (fr) Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2477148A1 (fr) Nouvelles 2 (1h)-pyridones, leur preparation et leur application comme medicaments
CA2032988C (fr) Procede de preparation de derives de la 1-phenyl imidazoline 2,5-dione
FR2696740A1 (fr) Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
EP0040591A1 (fr) Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique
EP0012639B1 (fr) Nouveaux dérivés de l'acide 3-quinoléine carboxylique, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant
EP0110781A1 (fr) (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant
BE1000573A4 (fr) Derives de 1-(hydroxystyryl)-5h-2,3-benzodiazepine, procede pour les preparer et compositions pharmaceutiques les contenant.
FR2527206A1 (fr) Nouveaux derives de la 2(1h)-pyridinone, leur preparation et leur utilisation comme medicaments
FR2612517A1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
FR2529786A1 (fr) Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
FR2662692A1 (fr) Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
CA1265803A (fr) Amides substitues, leur preparation et les medicaments qui les contiennent
BE896678A (fr) Nouveaux derives de la 2 (1h)-pyridinone, leur preparation et leur utilisation comme medicaments.
EP0094283B1 (fr) Forme médicamenteuse de théophylline à action prolongée
EP0176444B1 (fr) Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant
EP0183577B1 (fr) Dérivés du thiadiazole actifs sur le système nerveux central, procédé d'obtension et compositions pharmaceutiques les contenant
FR2552083A1 (fr) Derives de (alkynyloxy-3 hydroxy-2-propyl)-4 piperazinyl-1 n-phenyl acetamide, leur preparation et leur application en therapeutique
BE897473A (fr) Nouveaux alcaloides de l'ergot de seigle leur preparation et leur utilisation comme medicaments
BE887737A (fr) Nouvelles 2(1h)-pyridones, leur preparation et leur application comme medicaments
FR2475543A1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
CA1106376A (fr) Procede de preparation de nouveaux esters anthraniliques

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19900531